Circulating Tumor Cell (CTC) Market Size & Growth | Report 2028
循环肿瘤细胞 ( CTC ) 诊断市场规模预计将从 2021 年的 19.0941 亿美元增至 2028 年的 36.5638 亿美元;预计2021 年至 2028 年的复合年增长率为 9.7%。
循环肿瘤细胞 ( CTC ) 在癌症诊断和治疗方面具有巨大潜力。许多技术已经开发出来并不断改进,以提高其检测、分离、富集和分析CTC的效率。最常用的CTC检测和分离方法是基于免疫的检测,其中抗体选择性地结合细胞表面抗原。肿瘤细胞表达与血细胞不同的细胞表面标志物,并与循环细胞分离。CTC有助于检测原发组织中存在的小细胞亚群,这些细胞亚群最终可能导致治疗耐药性或疾病复发。因此,检测和表征CTC可能成为治疗实体肿瘤恶性肿瘤的必然步骤。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
循环肿瘤细胞(CTC)诊断市场:
Circulating Tumor Cell (CTC) Diagnostics Market: Strategic Insights
Circulating Tumor Cell (CTC) Diagnostics Market
-
CAGR (2021 - 2028)
9.7%
-
Market Size 2021
US$ 1.91 Billion
-
Market Size 2028
US$ 3.66 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Thermo Fisher Scientific Inc
- STEMCELL Technologies Inc
- QIAGEN
- Precision Medicine Group LLC
- Advanced Cell Diagnostics Inc BIO TECHNE CORPORATION
- Epic Sciences
- ScreenCell
- Ikonisys Inc
- IVDiagnostics
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
技术(CTC 检测和富集方法、CTC 直接检测方法和 CTC 分析)
应用(临床/液体活检和研究)
最终用户(医院和诊所、研究和学术机构以及诊断中心)
Circulating Tumor Cell (CTC) Diagnostics Market: Strategic Insights
-
CAGR (2021 - 2028)9.7% -
Market Size 2021
US$ 1.91 Billion -
Market Size 2028
US$ 3.66 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Thermo Fisher Scientific Inc
- STEMCELL Technologies Inc
- QIAGEN
- Precision Medicine Group LLC
- Advanced Cell Diagnostics Inc BIO TECHNE CORPORATION
- Epic Sciences
- ScreenCell
- Ikonisys Inc
- IVDiagnostics
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2021 - 2028 年)9.7%- 2021 年市场规模
19.1 亿美元 - 2028 年市场规模
36.6 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 赛默飞世尔科技公司
- STEMCELL技术公司
- 凯杰公司
- 精准医学集团有限责任公司。
- Advanced Cell Diagnostics, Inc.(BIO-TECHNE CORPORATION)
- 史诗科学
- 屏幕单元
- Ikonisys公司
- 静脉诊断
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- CTC 检测和富集方法
- CTC 直接检测方法
- CTC分析
- 临床/液体活检和研究
- 医院和诊所
- 研究与学术机构
- 诊断中心
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
循环肿瘤细胞(CTC) 诊断市场根据技术、应用、最终用户和地域进行细分。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。该报告提供了对市场的见解和深入分析,强调了市场趋势、技术进步和市场动态等参数,以及对全球领先市场参与者的竞争格局的分析。
市场洞察
预测期内,微创诊断程序需求不断增长,推动循环肿瘤细胞 (CTC) 诊断市场增长
越来越多的患者倾向于采用微创或非侵入性手术进行诊断。使用循环肿瘤细胞诊断法,可以进行早期癌症检测、突变检测、治疗期间的肿瘤监测和复发监测,这是一种非侵入性方法。研究人员可以使用含有循环肿瘤细胞的血液样本追踪实体肿瘤中的所有表观遗传和遗传变化。患者接受这些测试的风险较小,临床医生可以轻松地多次进行这些测试。患者更喜欢微创手术,因为此类手术中使用的先进仪器可以进行更精细、更复杂的工作,风险更低、疼痛更少、疤痕更少。
由于技术在可行性和处理时间方面的进步,循环肿瘤细胞诊断和液体活检最近引起了人们的极大兴趣,成为癌症患者组织活检的非侵入性替代方法。随着对改进的微创癌症检测技术的了解不断增加,液体活检的采用将得到促进。市场增长将受到对非侵入性工具的需求不断增长以及实验室对 CTC 测试和液体活检的接受度的影响。液体活检是一种非侵入性且简单的手术活检替代方法,可让医生从简单的血液样本中发现有关肿瘤的一系列信息。血液测试无痛、无创、无风险,并降低了诊断问题的成本和时间。此外,可以在血液样本中检测到 CTC、cfDNA、外泌体和微泡,使基于血液的液体活检更受欢迎。因此,对微创诊断测试的需求增加正在刺激市场增长。
技术洞察
根据技术,全球循环肿瘤细胞 (CTC) 诊断市场细分为 CTC 检测和富集方法、CTC 直接检测方法和 CTC 分析。2020 年,CTC 检测和富集细分市场占据了最大的市场份额。此外,预计同一细分市场将在 2021-2028 年期间实现最高的复合年增长率。借助 CTC 诊断,可以尽早诊断个人。因此,这些技术的采用正在增加,预计将在预测期内推动市场发展。
应用程序洞察
根据应用,全球循环肿瘤细胞 (CTC) 诊断市场分为临床/液体活检和研究。2020 年,研究部分占据了更大的市场份额,预计同一部分在 2021-2028 年期间将在市场上实现更高的复合年增长率。由于全球各种医疗状况的检测和诊断增加,预计未来市场将增长。
最终用户见解
根据最终用户,循环肿瘤细胞 (CTC) 诊断市场细分为医院和诊所、研究和学术机构以及诊断中心。研究和学术机构部门在 2021 年占据了最大的市场份额,预计在预测期内将实现市场最高复合年增长率。癌症诊断和治疗发展研究的增加、对癌症诊断的认识不断提高以及政府和其他企业的大量投资是支持研究和学术机构部门市场增长的一些关键因素。
产品发布和并购是全球循环肿瘤细胞 (CTC) 诊断市场参与者广泛采用的策略。以下列出了一些近期的关键市场发展:
- 2022年1月,赛默飞世尔科技公司宣布以总现金收购价约18.5亿美元全面收购PeproTech。
- 2021 年 12 月,Epic Sciences, Inc. 宣布推出 DefineMBC,这是一项新型转移性乳腺癌 (MBC) 测试,包括通过单次采血进行的基于细胞和无细胞的分析。
COVID-19 疫情对癌症患者和癌症监测能力产生了负面影响。此外,由于疫情,资源和医疗资源减少,使得癌症检测和治疗变得困难,导致死亡率上升,存活率下降。由于癌症和/或其治疗导致免疫系统受损,癌症患者容易受到传染性病原体(例如手术和化疗)的感染。这引发了人们对 COVID-19 问题和死亡可能在癌症患者中很常见的担忧。因此,疫情对循环肿瘤细胞 (CTC) 诊断市场产生了负面影响。
循环肿瘤细胞 (CTC) 诊断市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 19.1亿美元 |
2028 年市场规模 | 36.6亿美元 |
全球复合年增长率(2021 - 2028) | 9.7% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按技术分类
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
循环肿瘤细胞 (CTC) 诊断市场细分
全球循环肿瘤细胞 (CTC) 诊断市场根据技术、应用、最终用户和地域进行细分。就技术而言,市场细分为 CTC 检测和富集方法、CTC 直接检测方法和 CTC 分析。根据应用,全球循环肿瘤细胞 (CTC) 诊断市场分为临床/液体活检和研究。根据最终用户,循环肿瘤细胞 (CTC) 诊断市场细分为医院和诊所、研究和学术机构以及诊断中心。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。
公司简介
- 赛默飞世尔科技公司
- STEMCELL 技术公司
- 凯杰公司
- 精准医学集团有限责任公司
- Advanced Cell Diagnostics 公司(BIO-TECHNE 公司)
- 史诗科学
- 屏幕单元
- Ikonisys 公司
- 静脉诊断
- Fluxion Biosciences Inc0
Circulating Tumor Cell (CTC) Diagnostics Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 1.91 Billion |
Market Size by | US$ 3.66 Billion |
Global CAGR | 9.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 技术(CTC 检测和富集方法、CTC 直接检测方法和 CTC 分析) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
A Circulating Tumor Cell (CTC) is a cell that shed into lymphatics from the primary tumor and carried out throughout the body with blood circulation. Circulating tumor cells are the seeds for growth and metastases for additional tumors in distant organs and is responsible for majority of cancer related deaths. The diagnosis, detection and analysis of CTC can assist in patients’ prognoses determine appropriate tailored treatments for the patients. The CTC diagnosis has a lot of advantages for traditional diagnostic procedures. The advantages of CTC detection include, it is non-invasive, effective and can be used repeatedly. The CTC detection and enrichment, CTC direct detection and CTC analysis are the technologies used for CTC detection.
Key factors that are driving the growth of this market are increasing prevalence of cancer across the globe along with rising demand for minimally invasive diagnostic procedures.
The CTC detection and enrichment method segment dominated the global circulating tumor cell (CTC) diagnostics market and held the largest revenue share of 62.85% in 2021.
The research segment dominated the global circulating tumor cell (CTC) diagnostics market and accounted for the largest revenue share of 67.65% in 2021.
Global circulating tumor cell (CTC) diagnostics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the factors such as most foreign companies in the healthcare sector have R&D centres in the United States. Moreover, the increase in prevalence of cancer in the country along with various organic and inorganic developments done by the companies. And, Asia Pacific is the fastest-growing region growing at the CAGR of 10.3% during the forecast period.
The circulating tumor cell (CTC) diagnostics market majorly consists of the players such as Thermo Fisher Scientific, Stemcell Technologies, Inc, QIAGEN, Precision Medicine Group, LLC, Advanced Cell Diagnostics (Bio-Techne Corporation), Epic Lifesciences, Screencell, Ikonisys, Inc, IV Diagnostics, Fluxion Biosciences, among others
The List of Companies - Circulating Tumor Cell (CTC) Diagnostics Market
- Thermo Fisher Scientific Inc.
- STEMCELL Technologies Inc.
- QIAGEN
- Precision Medicine Group, LLC.
- Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)
- Epic Sciences
- ScreenCell
- Ikonisys, Inc.
- IVDiagnostics
- Fluxion Biosciences Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.